Literature DB >> 1679656

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.

D Jack1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1679656      PMCID： PMC1368467          DOI： 10.1111/j.1365-2125.1991.tb05571.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  26 in total

Review 1.  Sympathomimetic bronchodilator drugs.

Authors:  R T Brittain; C M Dean; D Jack
Journal:  Pharmacol Ther B       Date:  1976

2.  Three-dimensional model of purple membrane obtained by electron microscopy.

Authors:  R Henderson; P N Unwin
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

Review 3.  G protein coupling of receptors to ionic channels and other effector systems.

Authors:  L Birnbaumer; A Yatani; A M VanDongen; R Graf; J Codina; K Okabe; R Mattera; A M Brown
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

4.  Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.

Authors:  J P Bilezikian; A M Dornfeld; D E Gammon
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

5.  The inducement of tone and its inhibition in isolated tracheal muscle.

Authors:  R A Coleman; J B Farmer
Journal:  J Pharm Pharmacol       Date:  1971-03       Impact factor: 3.765

Review 6.  Recent beta-adrenoreceptor stimulants.

Authors:  R T Brittain; D Jack; A C Ritchie
Journal:  Adv Drug Res       Date:  1970

7.  Quinterenol, a new beta adrenergic stimulant.

Authors:  A Scriabine; P F Moore; L C Iorio; I M Goldman; W K McShane; K D Booher
Journal:  J Pharmacol Exp Ther       Date:  1968-07       Impact factor: 4.030

Review 8.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

9.  Saligenin analogs of sympathomimetic catecholamines.

Authors:  D T Collin; D Hartley; D Jack; L H Lunts; J C Press; A C Ritchie; P Toon
Journal:  J Med Chem       Date:  1970-07       Impact factor: 7.446

10.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321
View more
  21 in total

Review 1.  Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma.

Authors:  J C Adkins; D McTavish
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Current issues with beta2-adrenoceptor agonists: historical background.

Authors:  Anne E Tattersfield
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 3.  On the mechanism of the persistent action of salmeterol: what is the current position?

Authors:  R A Coleman
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

4.  Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice.

Authors:  Gloria S Forkuo; Hosu Kim; Vaidehi J Thanawala; Nour Al-Sawalha; Daniel Valdez; Radhika Joshi; Sergio Parra; Tonio Pera; Patricia A Gonnella; Brian J Knoll; Julia K L Walker; Raymond B Penn; Richard A Bond
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 5.  Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  R N Brogden; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 6.  Dose-response of inhaled drugs in asthma. An update.

Authors:  D J Clark; B J Lipworth
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of salmeterol.

Authors:  Mario Cazzola; Renato Testi; Maria Gabriella Matera
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.

Authors:  Milind P Sovani; Christopher I Whale; Anne E Tattersfield
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.

Authors:  A T Nials; M J Sumner; M Johnson; R A Coleman
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

10.  Allosteric modulators of class B G-protein-coupled receptors.

Authors:  Sam R J Hoare
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.